Publisher
Japanese Circulation Society
Reference17 articles.
1. 1) Owan TE, Hodge DO, Herges RM et al: Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2006; 355: 251-259
2. 2) Cleland JG, Tendera M, Adamus J et al: The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27: 2338-2345
3. 3) Massie BM, Carson PE, McMurray JJ et al: Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction. N Engl J Med 2008; 359: 2456-2467
4. 4) Solomon SD, McMurray JJV, Anand IS et al: Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. N Engl J Med 2019; 381: 1609-1620
5. 5) Pitt B, Pfeffer MA, Assmann SF et al: Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014; 370: 1383-1392